Loading…
Korean beauty company behind the Medicube brand, selling skincare products and at-home beauty devices globally.
Korean beauty company behind the Medicube brand, selling skincare products and at-home beauty devices globally.
Sells largely through e-commerce and marketplaces, driving demand with heavy social-media and influencer marketing, so sales depend on brand buzz more than store shelves. Most sales now come from overseas rather than Korea. Devices carry higher prices than skincare, and the two are cross-sold.
In one line: Korea's e.l.f. Beauty crossed with a beauty-tech gadget maker..
Moat: narrow (brand, distribution). Fast-growing, socially viral Medicube brand with new US retail distribution (Ulta), but beauty trends can fade quickly.
Headquarters: Seoul, South Korea · Founded: 2014 · Employees: 657
Size APR (278470.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $7.04B, the 57th largest of 495 South Korea companies the cockpit tracks. Shares closed at ₩255,500 on 6 Nov 2026.
Performance Over six months the shares fell 39.8%, against +12.5% for the median peer and -24.5% for the South Korea market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue grew 119.1% over the last twelve months (peer median +6.2%); the operating margin is 23.2% (peer median 13.2%).
Valuation It trades at 17.4× forward earnings against a peer median of 23.8× (7th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about -1% a year for seven years (Req g). Recent delivered growth is +47%, so the hurdle is -49 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 96.1 points above its cost of capital (6.5% WACC).
Next results Next results expected around 15 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩2.68T | ₩1.53T | ₩723B | ₩524B | ₩398B |
| Revenue growth | — | +111% | +38% | +32% | — |
| Gross profit | n/a | ₩1.14T | ₩524B | ₩382B | ₩281B |
| EBITDA | n/a | ₩396B | ₩145B | ₩118B | ₩50.0B |
| Net income | ₩468B | ₩290B | ₩108B | ₩81.5B | ₩29.0B |
| Free cash flow | n/a | ₩324B | ₩30.6B | ₩97.4B | ₩25.3B |
| Capital expenditure | n/a | ₩17.9B | ₩47.8B | ₩11.9B | ₩6.92B |
| Total debt | n/a | ₩101B | ₩109B | ₩22.2B | ₩34.5B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| APR 278470.KS | $7.04B | -40% | +119% | 23% | 17.4× | -1.4% |
| e.l.f. Beauty ELF | $6.85B | +91% | +31% | 12% | 35.4× | 27.9% |
| Amorepacific 090430.KS | $6.03B | -1% | +10% | 9% | 23.8× | 4.0% |
| LG H&h 051900.KS | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% |
| L'Oreal OR.PA | $268B | +25% | +3% | 21% | 32.8× | 18.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 278470.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -32.6% | +9.6% | lowest of 21 |
| 6-month return | -39.8% | +12.5% | lowest of 21 |
| Distance from 52-week high | -46.2% | -10.2% | lowest of 21 |
| Revenue growth (TTM) | +119.1% | +6.2% | 2nd highest of 21 |
| Operating margin | 23.2% | 13.2% | 4th highest of 21 |
| Forward P/E | 17.4× | 23.8× | 7th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | -1.4% | 4.7% | 7th least demanding of 20 |
| Growth delivered (Del g) | +47.3% | +5.4% | highest of 20 |
| Hurdle (Req g minus delivered) | -48.7 pp | -2.8 pp | least demanding of 20 |
| ROIC minus cost of capital | +96.1 pp | +4.2 pp | highest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| APR 278470.KS | South Korea | $7.04B | -40% | +119% | 23% | 17.4× | -1.4% | +47.3% |
| Dabur India DABUR.NS | India | $7.13B | -19% | +9% | 15% | 32.1× | 27.3% | +6.6% |
| e.l.f. Beauty ELF | United States | $6.85B | +91% | +31% | 12% | 35.4× | 27.9% | +38.8% |
| Amorepacific 090430.KS | South Korea | $6.03B | -1% | +10% | 9% | 23.8× | 4.0% | -0.8% |
| Godrej Consumer Products GODREJCP.NS | India | $9.19B | -18% | +12% | 18% | 37.0× | 31.7% | +6.6% |
| Shiseido 4911.T | Japan | $9.52B | +20% | +5% | 4% | 32.8× | 17.5% | +1.0% |
| Reynolds Consumer Products REYN | United States | $5.08B | +10% | +2% | 14% | 14.6× | -0.2% | +2.7% |
| Mao Geping Cosmetics 1318.HK | Hong Kong | $4.92B | -28% | +32% | 31% | 15.0× | 4.7% | +41.1% |
| Cupid CUPID.NS | India | $4.83B | +158% | +122% | 34% | n/a | n/a | n/a |
| Colgate-Palmolive (India) COLPAL.NS | India | $4.83B | -23% | +9% | 28% | 32.2× | 30.8% | +4.5% |
| Interparfums IPAR | United States | $4.34B | +43% | +3% | 17% | 29.0× | 10.9% | +22.5% |
| Clorox CLX | United States | $12.1B | +8% | +6% | 14% | 17.4× | 2.7% | -1.8% |
| Unicharm 8113.T | Japan | $12.1B | +15% | 0% | 12% | 24.5× | -2.0% | +5.4% |
| Marico MARICO.NS | India | $12.3B | +8% | +20% | 16% | 51.8× | 28.0% | +11.1% |
| Rohto Pharmaceutical 4527.T | Japan | $3.97B | +17% | +10% | 12% | 16.7× | -2.1% | +13.7% |
| Puig Brands PUIG.MC | Spain | $12.5B | +16% | +4% | 16% | 17.9× | -3.0% | +11.7% |
| Coty COTY | United States | $3.57B | +64% | -1% | 5% | 13.3× | 11.3% | +4.6% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.29B | +20% | +4% | 6% | 50.2× | 17.6% | +1.9% |
| Hengan Int'l 1044.HK | Hong Kong | $3.28B | -16% | +2% | 11% | 9.1× | -8.8% | -0.1% |
| Lion 4912.T | Japan | $3.19B | +21% | +6% | 8% | 19.9× | -2.4% | +3.5% |
| Proya Cosmetics 603605.SS | China | $2.97B | -19% | +2% | 13% | 11.1× | -4.8% | +23.1% |